About The Study: In this study, attention-deficit/hyperactivity disorder (ADHD) medication remained associated with reduced risks of several serious real-world outcomes (self-harm, unintentional injury, traffic crashes, and crime). However, the magnitude of these associations appears to have decreased alongside rising prescription rates over time. Thus, it is important to regularly evaluate medication use in different patient populations.
Corresponding Authors: To contact the corresponding authors, email Zheng Chang, PhD, ( zheng.chang@ki.se ) and Lin Li, PhD, ( lin.li@ki.se ).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2025.1281)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2025.1281?guestAccessKey=45a71930-b430-4659-9128-874af81300d0&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062525
JAMA Psychiatry